US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 5.970
  • -0.140-2.29%
Close May 16 16:00 ET
  • 5.960
  • -0.010-0.17%
Post 16:27 ET
410.77MMarket Cap-2518P/E (TTM)

C4 Therapeutics Key Stats

C4 Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

3.04M

-19.15%
EPS(YoY)

-0.41

+42.25%

Buy

May 12, 2024

C4 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.680M--
--2024/Q2-- / 5.117M--
--2024/Q13.039M / 9.283M--
--2023/Q43.261M / 3.213M--
--2023/Q311.072M / 5.460M--
--2023/Q22.664M / 6.439M--
--2023/Q13.759M / 5.463M--
--2022/Q42.854M / 10.943M--
--2022/Q36.754M / 9.262M--
--2022/Q213.834M / 8.507M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 7.680M--
--2024/Q2-- / 5.117M--
--2024/Q13.039M / 9.283M--
--2023/Q43.261M / 3.213M--
--2023/Q311.072M / 5.460M--
--2023/Q22.664M / 6.439M--
--2023/Q13.759M / 5.463M--
--2022/Q42.854M / 10.943M--
--2022/Q36.754M / 9.262M--
--2022/Q213.834M / 8.507M--

Unlock Free Earnings Estimates

C4 Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 12, 2024

Buy

  • Buy

    62.50%
  • Hold

    37.50%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg